WPCT sees £43m drop in value of Prothena stake value Woodford Patient Capital Trust (WPCT) lost £43m on its investment in Prothena last month, following the failure of the company’s NEOD001 for AL amyloidosis, according to an analysis of its portfolio by Marten & Co. Having for some time last year been WPCT’s largest investment, […]
Invesco Perpetual Enhanced Income agrees to EGM request – Invesco Perpetual Enhanced Income (IPE) has received requests from some of its largest institutional shareholders to hold an extraordinary general meeting. The shareholders are Invesco Perpetual, Practical Investment Fund and GAM Star Credit Opportunities. The shares are held by Bank of New York (Nominees) Limited, on behalf […]
Biotech Growth doubles down on Biogen and Alexion OrbiMed-managed Biotech Growth Trust (BIOG) appears to have increased its already substantial positions in Biogen and Alexion and reduced (or possibly even sold) its previously large stake in Regeneron in the last month, according to its an analysis of its top holdings by Marten & Co. The […]
MedicX reports on positive performance – MedicX Fund (MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom and Republic of Ireland, announced its results for the six month period to 31 March 2018. The company became a REIT on 1 October 2017. The company reported a 8.0% total […]
First annual report from Warehouse REIT Warehouse REIT (WHR), which listed on the London Alternative Investment Market (AIM) on 20 September 2017, has released preliminary annual results for the period from IPO to 31 March 2018. The IPO, which was oversubscribed, raised net proceeds of £146.8 million. On admission to AIM, the company completed the acquisition of the seed […]
Schroder Real Estate Investment Trust see 48% increase in profits – Schroder Real Estate Investment Trust (SREI) use the headline “winning cities focus and asset management driving outperformance” for the full year results for the year ended 31 March 2018. The company’s NAV rose by 6.4% and delivered a NAV total return of 10.5%. It outperformed the MSCI peer group […]
Strong occupancy performance driving 7% revenue growth at Big Yellow – The Big Yellow Group (BYG) has reported its annual results to 31 March 2018. When the company reported its results in May 2017, the company emphasised its ambition to achieve its long held occupancy target of 85%. In November that year, it raised that to 90%. The company […]
JZ Capital Partners releases its annual results to 28th February 2018 – JZ Capital Partners (JZCP), which invests in US and European micro-cap companies and US real estate, announced its annual results for the twelve-month period ended 28 February 2018. Results and Portfolio Highlights NAV of $837.6 million, down 1.4% on the previous year NAV per […]
Investment Trust Insider on Civitas and Horizon James Carthew: I hope Horizon revives faith in social housing Horizon Housing (HZN) real estate investment trust (Reit) is the latest launch in the burgeoning social housing sub-sector. At one point, investors were falling over themselves to invest in this area, attracted by its stable, secure and inflation-linked […]
HBM boosts dividend by 20% after stellar year London-listed HBM Healthcare (HBMN) has proposed a CHF 7/share dividend for year to end April, a 20% rise, after a strong year in which it saw a 11% rise in NAV and 34% rise in share price, beating the broadest biotech index and all other sector specialist […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
